Director/PDMR Shareholding

RNS Number : 3714H

GlaxoSmithKline PLC

10 July 2012

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 10 July 2012 of an increase in their notional interests in Ordinary Shares at a price of 1483 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $46.01 per ADS following the notional re-investment of the dividend paid to shareholders on 5 July 2012.

	Ordinary Shares	ADSs
Sir Andrew Witty	17,355.460
Dr M M Slaoui		5,424.381
Mr S Dingemans	4,320.237
Mr S M Bicknell	1,771.247
Mrs D P Connelly		2,571.166
Mr M Dunoyer	2,159.116
Mr E J Gray	3,679.950
Mr S A Hussain	4,651.657
Mr W C Louv		1,583.230
Dr D Pulman		2,294.120
Mr D S Redfern	2,370.092
Ms C Thomas	3,342.490
Mr P C Thomson	668.434
Mr D E Troy		2,995.469
Dr P J T Vallance	4,078.349
Ms E Walmsley	2,711.825
Mr C Weber	590.548
Mrs V A Whyte	316.604

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

10 July 2012

 

END

 

 

RDSQBLFFLDFZBBX